LPGO — Lipigon Pharmaceuticals AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Lipigon Pharmaceuticals AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	28.5	9.64	31.9	11.8	10.2
Net Total Accounts Receivable
Net Total Receivables	0.589	0.969	1.25	2.05	0.853
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29.3	10.7	33.6	14.6	11.5
Other Long Term Assets
Total Assets	29.4	10.8	33.6	14.8	11.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.47	6.95	5.16	7.06	3.82
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.47	6.95	5.16	7.06	3.82
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	23	3.87	28.4	7.76	7.91
Total Liabilities & Shareholders' Equity	29.4	10.8	33.6	14.8	11.7
Total Common Shares Outstanding